# | Title | Journal | Year | Citations |
---|
|
1 | Global Cancer Incidence and Mortality Rates and Trends—An Update | Cancer Epidemiology Biomarkers and Prevention | 2016 | 2,933 |
2 | Global Patterns of Cancer Incidence and Mortality Rates and Trends | Cancer Epidemiology Biomarkers and Prevention | 2010 | 2,299 |
3 | Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review | Cancer Epidemiology Biomarkers and Prevention | 2005 | 1,850 |
4 | Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis | Cancer Epidemiology Biomarkers and Prevention | 2006 | 1,804 |
5 | Complementing the Genome with an "Exposome": The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology | Cancer Epidemiology Biomarkers and Prevention | 2005 | 1,752 |
6 | Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention | Cancer Epidemiology Biomarkers and Prevention | 2014 | 1,387 |
7 | The Enigmatic Epidemiology of Nasopharyngeal Carcinoma | Cancer Epidemiology Biomarkers and Prevention | 2006 | 1,111 |
8 | Epidemiologic and Molecular Prognostic Review of Glioblastoma | Cancer Epidemiology Biomarkers and Prevention | 2014 | 1,003 |
9 | Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium | Cancer Epidemiology Biomarkers and Prevention | 2009 | 930 |
10 | Global Cancer in Women: Burden and Trends | Cancer Epidemiology Biomarkers and Prevention | 2017 | 911 |
11 | Anticipating the “Silver Tsunami”: Prevalence Trajectories and Co-Morbidity Burden among Older Cancer Survivors in the United States | Cancer Epidemiology Biomarkers and Prevention | 2016 | 869 |
12 | Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent | Cancer Epidemiology Biomarkers and Prevention | 2007 | 727 |
13 | International Trends in Colorectal Cancer Incidence Rates | Cancer Epidemiology Biomarkers and Prevention | 2009 | 681 |
14 | Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005 | Cancer Epidemiology Biomarkers and Prevention | 2009 | 676 |
15 | Obesity and Cancer: The Role of Dysfunctional Adipose Tissue | Cancer Epidemiology Biomarkers and Prevention | 2009 | 633 |
16 | International Variation in Female Breast Cancer Incidence and Mortality Rates | Cancer Epidemiology Biomarkers and Prevention | 2015 | 602 |
17 | Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for Care | Cancer Epidemiology Biomarkers and Prevention | 2013 | 591 |
18 | Controlled Physical Activity Trials in Cancer Survivors: A Systematic Review and Meta-analysis | Cancer Epidemiology Biomarkers and Prevention | 2005 | 572 |
19 | Obesity and Risk of Colorectal Cancer: A Meta-analysis of 31 Studies with 70,000 Events | Cancer Epidemiology Biomarkers and Prevention | 2007 | 562 |
20 | Cancer Progress and Priorities: Lung Cancer | Cancer Epidemiology Biomarkers and Prevention | 2019 | 543 |
21 | Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis | Cancer Epidemiology Biomarkers and Prevention | 2014 | 533 |
22 | Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) | Cancer Epidemiology Biomarkers and Prevention | 2012 | 531 |
23 | Etiology of Hormone Receptor–Defined Breast Cancer: A Systematic Review of the Literature | Cancer Epidemiology Biomarkers and Prevention | 2004 | 484 |
24 | Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical Cancer | Cancer Epidemiology Biomarkers and Prevention | 2005 | 474 |
25 | Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects | Cancer Epidemiology Biomarkers and Prevention | 2008 | 451 |
26 | Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type | Cancer Epidemiology Biomarkers and Prevention | 2014 | 444 |
27 | A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer | Cancer Epidemiology Biomarkers and Prevention | 2006 | 435 |
28 | Accuracy of Self-Reported Cancer-Screening Histories: A Meta-analysis | Cancer Epidemiology Biomarkers and Prevention | 2008 | 434 |
29 | Increase in Incidence of Colorectal Cancer Among Young Men and Women in the United States | Cancer Epidemiology Biomarkers and Prevention | 2009 | 424 |
30 | Physical Activity and Survival after Diagnosis of Invasive Breast Cancer | Cancer Epidemiology Biomarkers and Prevention | 2008 | 417 |
31 | Survivors of Childhood Cancer in the United States: Prevalence and Burden of Morbidity | Cancer Epidemiology Biomarkers and Prevention | 2015 | 417 |
32 | Economic Burden of Cancer in the United States: Estimates, Projections, and Future Research | Cancer Epidemiology Biomarkers and Prevention | 2011 | 412 |
33 | Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition Cohort | Cancer Epidemiology Biomarkers and Prevention | 2005 | 409 |
34 | Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak? | Cancer Epidemiology Biomarkers and Prevention | 2010 | 403 |
35 | Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States | Cancer Epidemiology Biomarkers and Prevention | 2017 | 400 |
36 | Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study | Cancer Epidemiology Biomarkers and Prevention | 2007 | 395 |
37 | Cancer Survivors: A Booming Population | Cancer Epidemiology Biomarkers and Prevention | 2011 | 395 |
38 | The Association of Telomere Length and Cancer: a Meta-analysis | Cancer Epidemiology Biomarkers and Prevention | 2011 | 393 |
39 | Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences | Cancer Epidemiology Biomarkers and Prevention | 2005 | 390 |
40 | Psychosocial Outcomes and Health-Related Quality of Life in Adult Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study | Cancer Epidemiology Biomarkers and Prevention | 2008 | 385 |
41 | Sex Disparities in Cancer Mortality and Survival | Cancer Epidemiology Biomarkers and Prevention | 2011 | 381 |
42 | Association of Gain and Loss of Weight before and after Menopause with Risk of Postmenopausal Breast Cancer in the Iowa Women's Health Study | Cancer Epidemiology Biomarkers and Prevention | 2005 | 378 |
43 | Body Mass Index and Adenocarcinomas of the Esophagus or Gastric Cardia: A Systematic Review and Meta-analysis | Cancer Epidemiology Biomarkers and Prevention | 2006 | 378 |
44 | Differences in Breast Cancer Survival by Molecular Subtypes in the United States | Cancer Epidemiology Biomarkers and Prevention | 2018 | 378 |
45 | Is It Time to Abandon the Food Frequency Questionnaire? | Cancer Epidemiology Biomarkers and Prevention | 2005 | 376 |
46 | Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer | Cancer Epidemiology Biomarkers and Prevention | 2017 | 368 |
47 | Sex Disparities in Cancer Incidence by Period and Age | Cancer Epidemiology Biomarkers and Prevention | 2009 | 365 |
48 | Efficacy of Exercise Interventions in Modulating Cancer-Related Fatigue among Adult Cancer Survivors: A Meta-Analysis | Cancer Epidemiology Biomarkers and Prevention | 2011 | 360 |
49 | Plasma Vitamin D Metabolites and Risk of Colorectal Cancer in Women | Cancer Epidemiology Biomarkers and Prevention | 2004 | 359 |
50 | Medical Care Costs Associated with Cancer Survivorship in the United States | Cancer Epidemiology Biomarkers and Prevention | 2020 | 353 |